Evidence map›Paper›PMID 22514641›Full record

ArticlePloS one2012

Purification and structural characterization of siderophore (corynebactin) from Corynebacterium diphtheriae.

Sheryl Zajdowicz, Jon C Haller, Amy E Krafft, Steve W Hunsucker, Colin T Mant, Mark W Duncan, Robert S Hodges, David N M Jones, Randall K Holmes

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. UropathogenicbioRxiv : the preprint server for biology · 2023
    Article
  9. Article
  10. Recent developments in siderotyping: procedure and application.World journal of microbiology & biotechnology · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Iron and Virulence inFrontiers in cellular and infection microbiology · 2017
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sheryl ZajdowiczDepartment of Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Jon C Haller
Amy E Krafft
Steve W Hunsucker
Colin T Mant
Mark W Duncan
Robert S Hodges
David N M Jones
Randall K Holmes
University of Colorado Denver · USMetropolitan State University of Denver · USNational Institute of Allergy and Infectious Diseases · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Control of Bacterial Toxins by Viruses and PlasmidsR37AI014107 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, RANDALL K · 2005 to 2014
$5.0M
HPLC OF PEPTIDES AND PROTEINSR01GM061855 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI HODGES, ROBERT S · 2000 to 2010
$3.6M
NCI NIH HHS P30 CA046934NIAID NIH HHS R37 AI014107NIGMS NIH HHS R01 GM061855
6 · The paper itself

Abstract

During infection, Corynebacterium diphtheriae must compete with host iron-sequestering mechanisms for iron. C. diphtheriae can acquire iron by a siderophore-dependent iron-uptake pathway, by uptake and degradation of heme, or both. Previous studies showed that production of siderophore (corynebactin) by C. diphtheriae is repressed under high-iron growth conditions by the iron-activated diphtheria toxin repressor (DtxR) and that partially purified corynebactin fails to react in chemical assays for catecholate or hydroxamate compounds. In this study, we purified corynebactin from supernatants of low-iron cultures of the siderophore-overproducing, DtxR-negative mutant strain C. diphtheriae C7(β) ΔdtxR by sequential anion-exchange chromatography on AG1-X2 and Source 15Q resins, followed by reverse-phase high-performance liquid chromatography (RP-HPLC) on Zorbax C8 resin. The Chrome Azurol S (CAS) chemical assay for siderophores was used to detect and measure corynebactin during purification, and the biological activity of purified corynebactin was shown by its ability to promote growth and iron uptake in siderophore-deficient mutant strains of C. diphtheriae under iron-limiting conditions. Mass spectrometry and NMR analysis demonstrated that corynebactin has a novel structure, consisting of a central lysine residue linked through its α- and ε- amino groups by amide bonds to the terminal carboxyl groups of two different citrate residues. Corynebactin from C. diphtheriae is structurally related to staphyloferrin A from Staphylococcus aureus and rhizoferrin from Rhizopus microsporus in which d-ornithine or 1,4-diaminobutane, respectively, replaces the central lysine residue that is present in corynebactin.

Indexed as

Biological TransportCitratesCorynebacterium diphtheriaeEnterobactinFerric CompoundsIronMagnetic Resonance SpectroscopyOrnithineSiderophoresSpectrometry, Mass, Electrospray IonizationCitratescorynebactinEnterobactinFerric CompoundsIronOrnithinerhizoferrinSiderophoresstaphyloferrin A

Identifiers

PMID22514641
PMCPMC3326035
OpenAlexW2127947770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.